comprehensive -WSS

comprehensive

author：Wikipedia 2025-10-01 17:33:37 - browse：28188

Illustration of doctors and researchers using innovative technologies for medicine and healthcare with artificial intelligence. -- health tech coverage from STAT — Adobe

At first glance, the Coalition for Health AI looks like any technology lobbying group. Its membership — including Microsoft, Google, and many of the nation’s largest academic hospitals — forms a formidable presence in Washington.

But on Monday, the coalition forged a different deal with federal regulators. It will work with them to develop quality and safety standards for artificial intelligence, an experiment that will test whether industry and government can effectively partner in the regulation of a fast-moving technology.

The nonprofit announced that its board of directors will include leaders from the Food and Drug Administration and the Office of the National Coordinator for Health Information Technology — agencies that, until now, have been setting up guardrails for AI in health care on their own. Government staffers will now work alongside industry scientists to develop evaluation methods and address new questions posed by generative AI and its emerging applications.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Trump demands the U.S. pay no more for drugs than other countries … again
Next article： Medicare Advantage insurers face 0.2% cut to 2025 payments

hotspot

WSS

Pancreatic cancer early detection could be helped by AI

Alabama frozen embryo ruling has major implications for IVF clinics

White House pharmacy plagued with problems, investigation finds

Ed Silverman on new gene therapies, biosimilars, coffee, and more

New clues to why women have higher risk of autoimmune disorders

Ocular Therapeutix moves raise hopes, and Alnylam tries to calm some nerves

hotspot

comprehensive

knowledge

BioMarin wins approval for gene therapy to treat hemophilia A

A new nitrogen execution bill also undermines medical licensing

Medical leaders decry Supreme Court decision on affirmative action

Reconstructing family trees of blood cells may help predict disease

Peter Hotez and the public health issue of online harassment

FTC sues over Novant Health acquisition of two N.C. hospitals

Moonlake's readout produced a cash windfall. Risks remain

Readout LOUD podcast: Humira legacy, AbbVie CEO's retirement

Medical leaders decry Supreme Court decision on affirmative action

Medicare Advantage insurers face 0.2% cut to 2025 payments

hotspot

Readout Newsletter: Alnylam, Celldex, Roche, Zealand Pharma

In utero gene editing: an explainer

New clues to why women have higher risk of autoimmune disorders

STAT readers on older presidents, polypills, Medicare, and more

Neurocrine Biosciences, biotech based in San Diego, joins PhRMA

NIH study of ME/CFS points to clear biological hallmarks

entertainment

hotspot

hotspot

leisure time